SUPERNUS PHARMACEUTICALS, INC. Quarterly Common Stock, Shares Authorized from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Supernus Pharmaceuticals, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2011 to Q3 2024.
  • Supernus Pharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 130M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 130M 0 0% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 130M 0 0% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 130M 0 0% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 130M 0 0% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 130M 0 0% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 130M 0 0% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 130M 0 0% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 130M 0 0% Dec 31, 2022 10-Q 2023-11-08
Q3 2022 130M 0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 130M 0 0% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 130M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 130M 0 0% Dec 31, 2021 10-K 2023-03-09
Q3 2021 130M 0 0% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 130M 0 0% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 130M 0 0% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 130M 0 0% Dec 31, 2020 10-K 2022-04-13
Q3 2020 130M 0 0% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 130M 0 0% Jun 30, 2020 10-Q 2020-08-17
Q1 2020 130M 0 0% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 130M 0 0% Dec 31, 2019 10-K 2021-03-08
Q3 2019 130M 0 0% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 130M 0 0% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 130M 0 0% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 130M 0 0% Dec 31, 2018 10-K 2020-02-28
Q3 2018 130M 0 0% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 130M 0 0% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 130M 0 0% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 130M 0 0% Dec 31, 2017 10-K 2019-03-01
Q3 2017 130M 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 130M 0 0% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 130M 0 0% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 130M 0 0% Dec 31, 2016 10-K 2018-03-01
Q3 2016 130M 0 0% Sep 30, 2016 10-Q 2017-01-20
Q2 2016 130M 0 0% Jun 30, 2016 10-Q/A 2017-01-23
Q1 2016 130M 0 0% Mar 31, 2016 10-Q/A 2017-01-20
Q4 2015 130M 0 0% Dec 31, 2015 10-K 2017-03-16
Q3 2015 130M 0 0% Sep 30, 2015 10-Q/A 2017-01-20
Q2 2015 130M 0 0% Jun 30, 2015 10-Q/A 2017-01-23
Q1 2015 130M 0 0% Mar 31, 2015 10-Q/A 2017-01-20
Q4 2014 130M 0 0% Dec 31, 2014 10-K/A 2017-01-20
Q3 2014 130M 0 0% Sep 30, 2014 10-Q/A 2017-01-20
Q2 2014 130M Jun 30, 2014 10-Q 2014-08-12
Q1 2014 130M 0 0% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 130M 0 0% Dec 31, 2013 10-K 2015-03-12
Q3 2013 130M 0 0% Sep 30, 2013 10-Q 2013-11-13
Q1 2013 130M +67.4M +108% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 130M +67.4M +108% Dec 31, 2012 10-K 2014-03-21
Q3 2012 130M Sep 30, 2012 10-Q 2012-11-02
Q2 2012 130M Jun 30, 2012 10-Q 2012-08-13
Q1 2012 62.6M Mar 31, 2012 10-Q 2012-06-08
Q4 2011 62.6M Dec 31, 2011 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.